Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

3.5K
Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.5K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

3.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
3.0K
The Tumor Microenvironment02:17

The Tumor Microenvironment

8.3K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Base editing reveals an essential role for NANOG in human embryogenesis.

Nature·2026
Same author

Darolutamide versus abiraterone acetate-based triplets in patients with hormone-sensitive prostate cancer: real-world, head-to-head comparison from the ARON-3 study.

Minerva urology and nephrology·2026
Same author

Targeting DNA-PK: medicinal chemistry insights into small-molecule inhibitor discovery and optimisation.

RSC medicinal chemistry·2026
Same author

Exciton dispersion fine structure and deep ultraviolet optical conductivity of freestanding two-dimensional h-BN.

Nature communications·2026
Same author

Engineered Caf1 Constructs Encoding Laminin-332 Motifs: A Novel Approach for Enhanced Cutaneous Wound Healing.

The British journal of dermatology·2026
Same author

Exploring the 'train the trainer' model for delivering Making Every Contact Count (MECC) training at scale: A qualitative study.

British journal of health psychology·2026
Same journal

Bronchiolar adenoma-like lesions with atypical features beyond the classic morphological spectrum: integrating histomorphology and molecular profiles.

The Journal of pathology·2026
Same journal

Differences between mitotically old and young endometrial tumors.

The Journal of pathology·2026
Same journal

Knowledge gaps in tubular gut tumours: a critical appraisal of the 6th edition of the World Health Organization classification of tumours.

The Journal of pathology·2026
Same journal

Tumor Invasive Border Index (TIBI) in colorectal cancer: linking infiltrative morphology to molecular insights.

The Journal of pathology·2026
Same journal

Lipodystrophy and adipose tissue recovery are mediated by the Wnt/lipogenesis axis during skin fibrosis.

The Journal of pathology·2026
Same journal

Optical mapping reveals a higher level of large-scale structural variants in a family with paternally transmitted myotonic dystrophy and independent Parkinson's disease.

The Journal of pathology·2026
See all related articles

Related Experiment Video

Updated: Apr 20, 2026

How to Study Basement Membrane Stiffness as a Biophysical Trigger in Prostate Cancer and Other Age-related Pathologies or Metabolic Diseases
13:18

How to Study Basement Membrane Stiffness as a Biophysical Trigger in Prostate Cancer and Other Age-related Pathologies or Metabolic Diseases

Published on: September 20, 2016

10.3K

AGE-modified basement membrane cooperates with Endo180 to promote epithelial cell invasiveness and decrease prostate

Mercedes Rodriguez-Teja1, Julian H Gronau, Claudia Breit

  • 1Department of Surgery and Cancer, Imperial College London, UK; Departamento de Genética, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay.

The Journal of Pathology
|November 20, 2014
PubMed
Summary
This summary is machine-generated.

Age-related changes in prostate tissue stiffness promote cancer invasion. Blocking a specific domain in Endo180 reversed these invasive behaviors, suggesting a new therapeutic target for prostate cancer.

Keywords:
C-type lectin domainadvanced glycation endproductsageingbasement membranecell contractilitycollagen crosslinkingepitheliuminvasionmatrix stiffnessprostate cancer

More Related Videos

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

36.2K
A Cancer Cell Spheroid Assay to Assess Invasion in a 3D Setting
05:34

A Cancer Cell Spheroid Assay to Assess Invasion in a 3D Setting

Published on: November 20, 2015

34.5K

Related Experiment Videos

Last Updated: Apr 20, 2026

How to Study Basement Membrane Stiffness as a Biophysical Trigger in Prostate Cancer and Other Age-related Pathologies or Metabolic Diseases
13:18

How to Study Basement Membrane Stiffness as a Biophysical Trigger in Prostate Cancer and Other Age-related Pathologies or Metabolic Diseases

Published on: September 20, 2016

10.3K
An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

36.2K
A Cancer Cell Spheroid Assay to Assess Invasion in a 3D Setting
05:34

A Cancer Cell Spheroid Assay to Assess Invasion in a 3D Setting

Published on: November 20, 2015

34.5K

Area of Science:

  • Biochemistry
  • Cell Biology
  • Oncology

Background:

  • Age-related thickening and stiffening of the prostate basal lamina correlate with increased cancer risk.
  • Structural alterations in the basal lamina may trigger mechanotransduction pathways in prostate epithelial cells (PECs), promoting invasiveness.

Purpose of the Study:

  • To investigate if age-associated basal lamina changes induce mechanotransduction pathways in PECs, leading to cancer progression.
  • To explore the role of Endo180 and its CTLD2 domain in mediating these effects.

Main Methods:

  • Developed a 3D model of PEC acini with advanced glycation end-product (AGE)-induced basal lamina thickening and stiffening.
  • Utilized antibody-targeted blockade of Endo180's CTLD2 domain to assess its impact on PEC behavior.
  • Correlated in vitro findings with studies in Endo180 mutant mice and human prostate cancer data.

Main Results:

  • AGE-modified basal lamina induced contractility, loss of polarity, disrupted cell junctions, and invasion in PEC acini.
  • Targeted blockade of CTLD2 reversed these AGE-induced invasive changes.
  • In vivo and human data showed concordance, with increased Endo180 expression and AGE levels linked to prostate cancer progression.

Conclusions:

  • AGE-dependent basal lamina modification drives invasive behavior in non-transformed PECs through a mechanism linked to cancer progression.
  • Targeting CTLD2 within Endo180 presents a potential therapeutic strategy for prostate cancer and other diseases characterized by basal lamina stiffening.